Ortho Firms Feel DoJ Probe Price As Stocks Fall In Q1; Will Zimmer Diversify?
This article was originally published in The Gray Sheet
Executive Summary
The federal government's mounting scrutiny of orthopedic industry pricing practices for hip and knee replacement implants could convince Zimmer to more aggressively seek a presence in the artificial disc arena
You may also be interested in...
Zimmer Outlines Strategy For Minimizing Effect Of Ortho Pricing Pressures
Zimmer is looking to its minimally invasive surgery, its trabecular metal knee technology and its CIMA cross-linked polyethylene hip technology to help overcome pricing pressures within the orthopedics sector
Zimmer Outlines Strategy For Minimizing Effect Of Ortho Pricing Pressures
Zimmer is looking to its minimally invasive surgery, its trabecular metal knee technology and its CIMA cross-linked polyethylene hip technology to help overcome pricing pressures within the orthopedics sector
Large Ortho Firms Balance HCA Market Opportunity With Gainsharing Pitfalls
HCA will submit its orthopedic implant gainsharing proposal to the HHS Office of the Inspector General by June 1